Hand Acceleration Time Assessment With Ultrasound Doppler

Status Active, not recruiting

Clinical Trial Summary

Chronic upper limb ischemia syndrome is uncommon compared to lower limb ischemia, with several potential causes (e.g., arteriosclerosis, compressive syndromes, arteritis, connective tissue diseases, trauma, and thrombosis). Many patients with upper limb ischemia remain asymptomatic due to arterial collateral vascularization. Given the wide variety of potential causes for upper limb ischemia, the diagnosis may require different technical approaches. Doppler ultrasound is a non-invasive, accessible, non-radiating technique that provides direct arterial imaging, yielding valuable information on arterial anatomy and hemodynamics. Some authors have described the reliability of the arterial duplex ultrasound for lower limb assessment using the pedal acceleration time (PAT). The PAT provides real-time hemodynamic physiological information on the entire limb. The acceleration time (AT) is an ultrasound parameter which measures the time elapsed (in milliseconds, ms) from the beginning of the arterial Doppler waveform until the systolic peak, evaluating the morphology of the arterial waveform in real time. In a healthy individual, this time should be short (between 40 - 100 milliseconds), displaying a triphasic waveform with a systolic acceleration, a sudden diastolic fall, and a subsequent anterograde flow at the end of diastole. A more damped wave suggests proximal stenosis and the acceleration time has been correlated to different degrees of foot ischemia. Notably, the AT parameter has also been studied in other territories, such as the carotid and pulmonary arteries, coronary arteries, and the aorta. Hand acceleration time (HAT) has also been described very recently as a potential tool to assess hemodialysis access-induced ischemia, cardiogenic shock, and subclavian iatrogenic ischemic lesion. However, the HAT has not yet been properly characterized or validated. Our working hypothesis is that the HAT is a useful diagnostic tool for chronic upper limb ischemia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05977725
Study type	Observational
Source	Hospital Universitari de Bellvitge
Contact
Status	Active, not recruiting
Phase
Start date	June 1, 2023
Completion date	April 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01205776` - EXCEL Clinical Trial	N/A
Completed	`NCT02542267` - In-Stent Restenosis Post-Approval Study	N/A
Completed	`NCT01608035` - Sciatic Perineural Versus Stump Catheter for Below Knee Amputation	Phase 0
Completed	`NCT00987181` - Non-Contact Measurement of Aortic Compliance	N/A
Completed	`NCT00865124` - Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease	N/A
Completed	`NCT00759681` - ArterX Surgical Sealant, A Randomized Prospective Multicenter Trial	Phase 3
Completed	`NCT01182428` - XIENCE V: SPIRIT WOMEN Sub-study	Phase 4
Completed	`NCT00633659` - Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia	Phase 2
Completed	`NCT00341562` - Genomics of In-Stent Restenosis	N/A
Completed	`NCT00110604` - The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and Hearing	N/A
Completed	`NCT01355406` - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System	N/A
Not yet recruiting	`NCT02843854` - Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms	Phase 1
Completed	`NCT01205789` - EXCEL Clinical Trial (Universal Registry)	N/A
Completed	`NCT01229358` - Clinical Trial of a Silver Eluting Dressing System	Phase 4
Completed	`NCT01221610` - BIOLUX P-I First in Man Study	N/A
Recruiting	`NCT01358630` - Vascular and Periodontal Disease - Microbial, Genetic and Histological Causalities	N/A
Completed	`NCT00782015` - Effects of Almonds on Vascular Reactivity in Patients With Coronary Artery Disease	N/A
Completed	`NCT00805831` - Safety and Efficacy of Using HDH Device and Method - a Novel Sutureless Vascular Anastomosis	N/A
Withdrawn	`NCT00334724` - Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) Study	Phase 4
Active, not recruiting	`NCT02751099` - Bone and Cardiovascular Disease After Kidney Transplant

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Hand Acceleration Time Assessment With Ultrasound Doppler — HAT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms